ΥΛΗ ΒΙΟΧΗΜΕΙΑΣ ΙΙ
-
Upload
matina-sourridi -
Category
Documents
-
view
213 -
download
1
description
Transcript of ΥΛΗ ΒΙΟΧΗΜΕΙΑΣ ΙΙ
. .. . .. . .
. . .
. . .
.1. , . 2
2. DNA, , . 1
3. DNA, DNA 3
Devlin T . 2, 4 ,7
Lehninger T . 8, 9
. 24, 25.
.
4. RNA
2
5. - 2
6. 3
7.
4
.
Devlin T . 2, 4, 5, 6, 7, 8.
. 25.
Lehninger T . 8, 9, 12.8 , 12.10
. 24, 25, 26, 27, 28.
.
1. O (2 )
Devlin (23.1, 23.2)
Lehninger (23.1)2. -- (1 )
Devlin (. 23.3: . 1347-1351, . 23.4: . 1359-1365, . 23.6: . 1374-1378)
Loffler (.346-348, 375-376)
3. ( ) (1 )
Devlin (. 1351-1353)
Loffler (.352-360, 371-374)
4. (--) (1 )
Devlin ( 23.7, 23.8)
5. (1 )
6. (1 )
Lehninger (23.4) 7. (1 )
.
6
Lehninger 1149-1186
- 2
Devlin 23
1
Devlin (. 1393-1396)
. . 5
( DNA / / .
( ).
( , ).
.
.
Devlin 13 & 25
Lehninger 12 & 28
. 2
1. EGFR
2. HER-2
1) Devlin 13 & 252) Lehninger 12 & 283) M.V. Karamouzis & A.G. Papavassiliou: The IGF-1 network in lung carcinoma therapeutics, Trends Mol Med, 12:595-602, 2006.
4) M.V. Karamouzis, J.R. Grandis & A. Argiris: Therapies against epidermal growth factor receptor in aerodigestive carcinomas. JAMA, 298: 70-82, 2007.
5) M.V. Karamouzis, P.A. Konstantinopoulos & A.G. Papavassiliou: Trastuzumab Mechanism of action and use in clinical practice, New Engl J Med, 357: 1664, 2007.
6) M.V. Karamouzis, A. Argiris, D. Raben & R. Ferris: Head and Neck Cancer, Lancet, 371: 1695-1709, 2008.
7) M.V. Karamouzis, P.A. Konstantinopoulos, A.G. Papavassiliou: Targeting c-Met as a strategy to overcome cross-talk related resistance to EGFR protein -targeting agents in cancer therapeutics, Lancet Oncol, 10: 709-77, 2009.